Published on: May 18, 2017 at Spandidos Publications

Monoclonal antibodies against autocrine motility factor suppress gastric cancer

By : Spandidos Publications

A new study finds an antibody specific to autocrine motility factor – a secreted form of phosphoglucose isomerase that stimulates proliferation, survival and metastasis of cancer cells – may be a therapeutic agent for gastric cancer.

Read More
SHARE